BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

446 related articles for article (PubMed ID: 11461867)

  • 1. Hepatocellular carcinoma treated with radiofrequency ablation: comparison of pulse inversion contrast-enhanced harmonic sonography, contrast-enhanced power Doppler sonography, and helical CT.
    Meloni MF; Goldberg SN; Livraghi T; Calliada F; Ricci P; Rossi M; Pallavicini D; Campani R
    AJR Am J Roentgenol; 2001 Aug; 177(2):375-80. PubMed ID: 11461867
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radiofrequency thermal ablation of hepatocellular carcinoma: using contrast-enhanced harmonic power doppler sonography to assess treatment outcome.
    Cioni D; Lencioni R; Rossi S; Garbagnati F; Donati F; Crocetti L; Bartolozzi C
    AJR Am J Roentgenol; 2001 Oct; 177(4):783-8. PubMed ID: 11566673
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radiofrequency ablation of hepatocellular carcinoma: therapeutic response using contrast-enhanced coded phase-inversion harmonic sonography.
    Wen YL; Kudo M; Zheng RQ; Minami Y; Chung H; Suetomi Y; Onda H; Kitano M; Kawasaki T; Maekawa K
    AJR Am J Roentgenol; 2003 Jul; 181(1):57-63. PubMed ID: 12818830
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Percutaneous ablation therapy guided by contrast-enhanced sonography for patients with hepatocellular carcinoma.
    Numata K; Isozaki T; Ozawa Y; Sakaguchi T; Kiba T; Kubota T; Ito A; Sugimori K; Shirato K; Morimoto M; Tanaka K
    AJR Am J Roentgenol; 2003 Jan; 180(1):143-9. PubMed ID: 12490493
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is contrast-enhanced US alternative to spiral CT in the assessment of treatment outcome of radiofrequency ablation in hepatocellular carcinoma?
    Ricci P; Cantisani V; Drudi F; Pagliara E; Bezzi M; Meloni F; Calliada F; Erturk SM; D'Andrea V; D'Ambrosio U; Passariello R
    Ultraschall Med; 2009 Jun; 30(3):252-8. PubMed ID: 19280552
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contrast-enhanced power Doppler sonography and helical computed tomography for assessment of vascularity of small hepatocellular carcinomas before and after percutaneous ablation.
    Vilana R; Llovet JM; Bianchi L; Sanchez M; Pagés M; Sala M; Gilabert R; Nicolau C; Garcia A; Ayuso C; Bruix J; Bru C;
    J Clin Ultrasound; 2003; 31(3):119-28. PubMed ID: 12594796
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment response assessment of radiofrequency ablation for hepatocellular carcinoma: usefulness of virtual CT sonography with magnetic navigation.
    Minami Y; Kitai S; Kudo M
    Eur J Radiol; 2012 Mar; 81(3):e277-80. PubMed ID: 21392916
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiofrequency ablation of hepatocellular carcinoma: predicting success using contrast-enhanced sonography.
    Dill-Macky MJ; Asch M; Burns P; Wilson S
    AJR Am J Roentgenol; 2006 May; 186(5 Suppl):S287-95. PubMed ID: 16632690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatocellular carcinoma treated with percutaneous radio-frequency ablation: usefulness of power Doppler US with a microbubble contrast agent in evaluating therapeutic response-preliminary results.
    Choi D; Lim HK; Kim SH; Lee WJ; Jang HJ; Lee JY; Paik SW; Koh KC; Lee JH
    Radiology; 2000 Nov; 217(2):558-63. PubMed ID: 11058660
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic response assessment of percutaneous radiofrequency ablation for hepatocellular carcinoma: utility of contrast-enhanced agent detection imaging.
    Kim CK; Choi D; Lim HK; Kim SH; Lee WJ; Kim MJ; Lee JY; Jeon YH; Lee J; Lee SJ; Lim JH
    Eur J Radiol; 2005 Oct; 56(1):66-73. PubMed ID: 15913940
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ablation therapy guided by contrast-enhanced sonography with Sonazoid for hepatocellular carcinoma lesions not detected by conventional sonography.
    Numata K; Morimoto M; Ogura T; Sugimori K; Takebayashi S; Okada M; Tanaka K
    J Ultrasound Med; 2008 Mar; 27(3):395-406. PubMed ID: 18314518
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vascularization of liver tumors - preliminary results with Coded Harmonic Angio (CHA), phase inversion imaging, 3D power Doppler and contrast medium-enhanced B-flow with second generation contrast agent (Optison).
    Jung EM; Kubale R; Jungius KP; Jung W; Lenhart M; Clevert DA
    Clin Hemorheol Microcirc; 2006; 34(4):483-97. PubMed ID: 16687788
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison between color power Doppler ultrasound with echo-enhancer and spiral computed tomography in the evaluation of hepatocellular carcinoma vascularization before and after ablation procedures.
    Cedrone A; Pompili M; Sallustio G; Lorenzelli GP; Gasbarrini G; Rapaccini GL
    Am J Gastroenterol; 2001 Jun; 96(6):1854-9. PubMed ID: 11419839
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of therapeutic response in hepatocellular carcinoma treated with percutaneous radio frequency ablation: comparison of multiphase helical computed tomography and power Doppler ultrasonography with a microbubble contrast agent.
    Choi D; Lim HK; Kim SH; Lee WJ; Jang HJ; Kim H; Lee SJ; Lim JH
    J Ultrasound Med; 2002 Apr; 21(4):391-401. PubMed ID: 11934096
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation using contrast-enhanced harmonic gray scale sonography after radio frequency ablation of small hepatocellular carcinoma: sonographic-histopathologic correlation.
    Morimoto M; Nozawa A; Numata K; Shirato K; Sugimori K; Kokawa A; Tomita N; Saitou T; Nakatani Y; Imada T; Tanaka K
    J Ultrasound Med; 2005 Mar; 24(3):273-83. PubMed ID: 15723840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcatheter arterial chemoembolization of hepatocellular carcinoma: usefulness of coded phase-inversion harmonic sonography.
    Minami Y; Kudo M; Kawasaki T; Kitano M; Chung H; Maekawa K; Shiozaki H
    AJR Am J Roentgenol; 2003 Mar; 180(3):703-8. PubMed ID: 12591679
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radiofrequency ablation of liver cancer: early evaluation of therapeutic response with contrast-enhanced ultrasonography.
    Choi D; Lim HK; Lee WJ; Kim SH; Kim MJ; Kim SK; Jang KM; Lee JY; Lim JH
    Korean J Radiol; 2004; 5(3):185-98. PubMed ID: 15467416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contrast-enhanced, wide-band, phase inversion harmonic power Doppler imaging of hepatocellular carcinoma.
    Janica J; Serwatka W; Polaków J; Kordecki K; Łebkowska U; Walecki J; Dobrzycki S
    Med Sci Monit; 2004 Jun; 10 Suppl 3():32-5. PubMed ID: 16538196
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Using contrast-enhanced sonography to assess the effectiveness of transcatheter arterial embolization for hepatocellular carcinoma.
    Numata K; Tanaka K; Kiba T; Saito S; Isozaki T; Hara K; Morimoto M; Sekihara H; Yonezawa H; Kubota T
    AJR Am J Roentgenol; 2001 May; 176(5):1199-205. PubMed ID: 11312181
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of hepatocellular carcinoma with percutaneous radiofrequency ablation: usefulness of contrast harmonic sonography for lesions poorly defined with B-mode sonography.
    Minami Y; Kudo M; Kawasaki T; Chung H; Ogawa C; Shiozaki H
    AJR Am J Roentgenol; 2004 Jul; 183(1):153-6. PubMed ID: 15208130
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.